A state-of-the-art heart pump recently approved for use in end-stage cardiac patients has a significantly lower risk for infection than an earlier model of the device, according to researchers at Henry Ford Hospital in Detroit. Known as a left ventricular assist device, the newest version of the HeartMate is much smaller than the first and uses a tiny turbine with synthetic ruby bearings, lubricated by the blood itself, to continually push blood through the body.
In 1989 a 29-year-old Michael Schrader couldn’t envision wanting more—that is, more children. Taking steps to keep his nuclear family intact, he underwent a vasectomy. Divorce later frayed this family portrait, but in the years that followed, Schrader would revisit the issue of having children with his soon to be second wife.
According to the Journal of NeuroInterventional Surgery, a surgical treatment generally used on patients with tumors and brain disorders could put a stop to incessant nosebleeds. The surgery involves injecting coils into the arteries of the nose through arteries in the leg. For most people pressure and tissues work, but about one percent of the population – generally older adults on blood thinners – suffer from uncontrollable nosebleeds severe enough that surgery may be considered.
A cancer patient who has a phobia of hospitals should be forced to undergo a life-saving operation if necessary, a British judge recently ruled. He added that doctors could forcibly sedate the 55-year-old woman, who he feels lacks the capacity to make decisions about her health. Doctors feel she would die if her ovaries and fallopian tubes were not removed, as she was diagnosed with uterine cancer last year.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery. Heart surgeons from 15 centers in the federally sponsored Pediatric Heart Network studied the outcomes in 549 newborns who received a complex series of surgeries for hypoplastic left heart syndrome (HLHS).
Video from Society of Elite Laparoscopic Surgeons. Laparoscopic Uterine Anteversion is performed with a proprietary kit from Cooper Surgical. Metra is a simple technique to antevert a retroverted uterus particularly effective for women with collisional dyspareunia or endometriosis.
This is a 3-D demonstration of the Kumar T-Anchors* Hernia Set, invented by Dr Sabi Kumar.
Prefenz® Alcohol-Free Hand Sanitizer from Safety-Med Products, Inc. kills germs on contact and offers continuous protection for up to 24 hours or 10 hand washings with only one application. The Prefenz patented formula contains a silica complex that produces a protective, invisible, moisturizing barrier that prevents the drying, redness, chapping and flaking caused by alcohol-based products.
Covidien introduces the EEA™ Hemorrhoid & Prolapse Stapler Set with DST Series™ Technology. According to the company, the new instrumentation features advances in hemorrhoid stapler technology and design that address what surgeons say are their biggest challenges in performing the hemorrhoidopexy procedure.
Recently, TYRX, Inc. announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance to market AIGISRx® ST, an antibacterial product for the surgical repair of damaged or ruptured soft tissue. Surgical Products spoke with Daniel Lerner, MD, a cardiologist and chief medical officer at the company about the new development, and why it works to help surgeons and surgical staff in their fight against hospital-acquired infection (HAI).
My closest connection to the world of design and development is my dad – an electrical engineer who now works designing the chips that go inside pacemakers and heart defibrillators. Whenever I’m home I’ll ask him about how his latest project is going, if he has any new patents pending, or if I’d recognize any of the stuff he’s working on.
According to recent finings from HealthGrades, the number of bariatric surgeries being performed in the U.S. continues to rise, but the quality and safety of these procedures varies widely from one hospital to another, the study states. Overall rates of risk-adjusted, in-hospital complications and mortality related to obesity surgery are decreasing, according to the study.
JenaValve™ Technology, Inc., a medical device company specializing in transcatheter valve implantation systems, has announced completion of its first-in-man procedures for its transapical transcatheter aortic valve implantation (TAVI) system. The procedures and implantations were uccessfully performed in nine patients in Leipzig, Germany.